5M PRODUCT
Sorafenat 200mg Sorafenib Tosylate Tablet
Anticancer PHARMACEUTICAL PRODUCT

Sorafenat 200mg Sorafenib Tosylate Tablet

Strength 200 MG
Published by 5M Biotech India
Last updated 24 October 2026
Company Profile →
PRODUCT INFORMATION

About Sorafenat 200mg Sorafenib Tosylate Tablet

Product information published by 5M Biotech India.

Active Ingridient Sorafenib Tosylate
Brand Sorafenat
Country of origin India
Form Oral Tablet

Sorafenat 200mg Tablet is an anticancer medicine containing the active ingredient Sorafenib Tosylate. It is used in the treatment of certain types of advanced cancer, including liver, kidney, and thyroid.

Take this medicine as prescribed by your doctor. Taking it the wrong way or taking more than prescribed can cause side effects. This medicine may take a few weeks or months to show its benefits, but continue taking it until your doctor tells you to stop.

Clinical Uses

Uses of Sorafenat 200mg Tablet are as follows:

  • Advanced renal cell carcinoma (kidney cancer)
  • Advanced hepatocellular carcinoma (liver cancer)
  • Advanced papillary and follicular Hurtle cell thyroid carcinoma (thyroid cancer)

How It Works

Sorafenat 200mg Tablet contains Sorafenib, which is a multikinase inhibitor. It works by blocking the action of a specific protein called kinases, which are responsible for signaling cancer cells to grow and multiply. Sorafenib also blocks other proteins involved in angiogenesis, a process through which new blood vessels form from pre-existing blood vessels. By blocking these signals, Sorafenat 200mg Tablets slows the growth of cancer cells.

Side Effects

Side effects of Sorafenat 200 mg Tablet include:

  • Headache
  • Nausea
  • Vomiting
  • Dizziness
  • Diarrhea
  • Blurred vision
  • Skin rash
  • Fatigue
  • Abnormal pain
  • High blood pressure
  • Loss of appetite
  • Weight loss

This is not the complete list. If you experience any unusual discomfort, consult your doctor.

Precautions & Warnings

  • Avoid alcohol while taking Sorafenat 200mg Tablet as it may increase the risk of side effects.
  • Pregnant and breastfeeding women should avoid Sorafenat 200 mg Tablet.
  • Sorafenat 200 mg Tablet should be used with caution in severe kidney or liver disease.
  • This medication is not recommended for children below 18 years.
  • Sorafenat must be used with caution in patients with heart problems. Inform your doctor about any pre-existing heart problem.
  • This medication can cause dizziness, so drive with caution.
  • Sorafenat 200 mg Tablet must be used with extreme caution in elderly patients.

Drug Interactions

Sorafenat 200 mg Tablet can interact with some medications. Let your doctor know if you are taking any blood thinners, certain anti-seizure medications, and chemotherapy drugs.

Some drugs that can interact with Sorafenat 200mg Tablet include:

  • Clozapine
  • Hydroxycholoquine
  • Phenytoin
  • Pimozide
  • St. John’s wort
  • Rifampin
  • Ozanimod
  • Methadone

Disclaimer

At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.

All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.

All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.

Publisher 5M Biotech India
Last Updated 24 October 2026
Product Record #659
Therapeutic Area Anticancer
PRODUCT ENQUIRY

Discuss Sorafenat 200mg Sorafenib Tosylate Tablet